Search Results - "Bisaga, Adam"

Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials.

Authors: Shulman, Matisyahu Hu, Mei‐Chen Sullivan, Maria A. et al.

Source: American Journal on Addictions. Nov2025, Vol. 34 Issue 6, p654-662.

Commentary on Ezard et al.: Prescribed psychostimulant medications for methamphetamine use disorder – an urgent path forward.

Authors: Bisaga, Adam

Source: Addiction. Jul2025, Vol. 120 Issue 7, p1360-1362. 3p.

Subjects: Substance abuse, Combination drug therapy, Patient compliance, Methamphetamine, Patient safety, Central nervous system stimulants, Dose-effect relationship in pharmacology, Quality of life, Drugs

Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone.

Authors: Rudolph, Kara E. Inose, Shodai Williams, Nicholas T. et al.

Source: Addiction. Jan2026, Vol. 121 Issue 1, p117-125. 9p.

Subjects: Substance abuse, Drug withdrawal symptoms, Research funding, Secondary analysis, Nicotine, Descriptive statistics, Injections, Longitudinal method, Confidence intervals, Data analysis software, Naltrexone

Geographic Terms: United States

Telehealth for opioid use disorder: retention as a function of demographics and rurality.

Authors: Williams, Arthur Robin Aronowitz, Shoshana V. Rowe, Christopher et al.

Source: American Journal of Drug & Alcohol Abuse. 2023, Vol. 49 Issue 2, p260-265. 6p.

Subjects: Opioid abuse, COVID-19 pandemic, Telemedicine, Rurality, Race

Geographic Terms: New York (State), Pennsylvania

The acute and repeated effects of cigarette smoking and smoking‐related cues on impulsivity.

Authors: Martinez, Suky Jones, Jermaine D. Vadhan, Nehal P. et al.

Source: Drug & Alcohol Review. Jul2021, Vol. 40 Issue 5, p864-868. 5p. 1 Chart, 1 Graph.

Subjects: Smoking, Cigarette smoke, Impulsive personality, Nicotine addiction, Response inhibition

Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.

Authors: Tardelli, Vitor S. Bisaga, Adam Arcadepani, Felipe B. et al.

Source: Psychopharmacology. Aug2020, Vol. 237 Issue 8, p2233-2255. 23p. 1 Diagram, 3 Charts, 10 Graphs.

Subjects: Cocaine-induced disorders, Central nervous system stimulants, Opioid abuse, Substance-induced disorders, Medical prescriptions, Cocaine, Meta-analysis, Urinalysis

A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.

Authors: Sibai, Mohammad Mishlen, Kaitlyn Nunes, Edward V. et al.

Source: American Journal of Drug & Alcohol Abuse. 2020, Vol. 46 Issue 3, p289-296. 8p.

Subjects: Controlled release drugs, Naltrexone, Pilot projects, Substance abuse, Narcotic antagonists, Buprenorphine, Drug withdrawal symptoms, Intramuscular injections, Disease relapse, Controlled release preparations, Research funding

Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism.

Authors: Nunes, Edward V. Bisaga, Adam Krupitsky, Evgeny et al.

Source: Addiction. Feb2020, Vol. 115 Issue 2, p239-246. 8p. 2 Charts, 1 Graph.

Subjects: Opioid abuse, Controlled release preparations, Drug abuse treatment, Patient dropouts, Naltrexone

Development of a Cascade of Care for responding to the opioid epidemic.

Authors: Williams, Arthur Robin Nunes, Edward V. Bisaga, Adam et al.

Source: American Journal of Drug & Alcohol Abuse. 2019, Vol. 45 Issue 1, p1-10. 10p.

Subjects: National Institute on Drug Abuse, Buprenorphine, Drug overdose, Drug abuse, Research funding

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety.

Authors: Jones, Jermaine D. Bisaga, Adam Metz, Verena E. et al.

Source: Journal of Psychoactive Drugs. Nov-Dec2018, Vol. 50 Issue 5, p390-401. 12p.

Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism.

Authors: Nunes, Edward V. Bisaga, Adam Krupitsky, Evgeny et al.

Source: Addiction. Nov2020, Vol. 115 Issue 11, p2188-2190. 3p.

Subjects: Cognition, Motivation (Psychology), Naltrexone, Narcotics, Substance abuse

Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder.

Authors: Shulman, Matisyahu Greiner, Miranda Bisaga, Adam

Source: Addiction. Jan2024, Vol. 119 Issue 1, p158-159. 2p.

Subjects: Controlled release drugs, Naltrexone, Substance abuse, Central nervous system stimulants, Narcotic antagonists, Buprenorphine, Disease relapse, Risk assessment, Methamphetamine, Amphetamines, Cocaine, Drugs of abuse, Disease risk factors

Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.

Authors: Bisaga, Adam Mannelli, Paolo Sullivan, Maria A. et al.

Source: American Journal on Addictions. Apr2018, Vol. 27 Issue 3, p177-187. 11p. 1 Diagram, 2 Charts.

Subjects: Drug abuse treatment, Opioid abuse, Public health, Health of people with drug addiction, Medical care of people with drug addiction, Management, Substance abuse & psychology, Substance abuse treatment, Substance abuse diagnosis, Analgesics, Compulsive behavior, Drug withdrawal symptoms, Narcotics, Pharmacodynamics

Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders.

Authors: Williams, Arthur Robin Barbieri, Vincent Mishlen, Kaitlyn et al.

Source: American Journal on Addictions. Jun2017, Vol. 26 Issue 4, p319-325. 7p.

Subjects: Naltrexone, Drug abuse treatment, Opioid abuse, Substance abuse treatment, Drug side effects, Patient compliance, Therapeutics, Substance abuse & psychology, Narcotic antagonists, Controlled release preparations, Drugs, Health attitudes, Longitudinal method, Substance abuse

A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.

Authors: Levin, Frances R. Bisaga, Adam Sullivan, Maria A. et al.

Source: American Journal on Addictions. Dec2016, Vol. 25 Issue 8, p603-609. 7p.

Subjects: Drug therapy, Medical personnel training, Mentoring, Opioid abuse, American Academy of Addiction Psychiatry, Buprenorphine, Substance abuse treatment, General practitioners, Education, Public health, Research funding, Substance abuse

Geographic Terms: United States

Baseline characteristics of patients predicting suitability for rapid naltrexone induction.

Authors: Mogali, Shanthi Khan, Nabil A. Drill, Esther S. et al.

Source: American Journal on Addictions. Apr2015, Vol. 24 Issue 3, p258-264. 7p. 3 Charts, 1 Graph.

Subjects: Opioid abuse, Drug abuse treatment, Naltrexone, Clonidine, Logistic regression analysis, Psychosocial factors, Heroin

Continuing Increase in Stimulant Dependence – Time to Implement Medical Treatment.

Authors: Bisaga, Adam Tardelli, Vitor S. Gerra, Gilberto et al.

Source: Canadian Journal of Psychiatry. Jul2022, Vol. 67 Issue 7, p507-511. 5p.

Subjects: Cocaine, Amphetamines, Therapeutics, Health equity, Cocaine abuse, Harm reduction, Psychotherapy, Drugs

Google Trends Data: A Potential New Tool for Monitoring the Opioid Crisis.

Authors: Ghosh, Abhishek Bisaga, Adam Kaur, Simranjit et al.

Source: European Addiction Research. Jan2022, Vol. 28 Issue 1, p33-40. 8p.

Open-label pilot study of quetiapine treatment for cannabis dependence.

Authors: Mariani, John J. Pavlicova, Martina Mamczur, Agnieszka K. et al.

Source: American Journal of Drug & Alcohol Abuse. 2014, Vol. 40 Issue 4, p280-284. 5p.

Subjects: Quetiapine, Marijuana abuse, Substance abuse treatment, Drug dosage, Drug side effects, Drug tolerance

A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients.

Authors: Raby, Wilfrid Noel Rubin, Eric A. Garawi, Fatima et al.

Source: American Journal on Addictions. Jan2014, Vol. 23 Issue 1, p68-75. 8p.

Subjects: Venlafaxine, Antidepressants, Cocaine abuse treatment, Mental depression, Dysthymic disorder, Therapeutics